Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The FDA has sent three waves of warning letters to telehealth companies marketing compounded GLP-1s since September 2025, most recently 25 letters in June 2026, citing misleading claims that the product is the same as the FDA-approved drug and sellers that never disclose which pharmacy made the medication
PR Newswire Eli Lilly
On average, patients treated for obesity lost 8.4 % of their original body weight while on the medication, compared with a 4.4 % reduction among those treated for T2DM
Subcutaneous injections deliver nutrients into the fatty tissue under the skin
US$ 24.46
US$ 28.14
US$ 24.14
US$ 25.69
